Biocomposites announces that it has entered into a multi-year agreement with Zimmer Biomet to exclusively distribute genex Bone Graft Substitute with its new mixing system and delivery options in the U.S. orthopaedic market. genex Bone Graft Substitute is a biphasic composite of exceptional purity that is specifically formulated to balance osteoconductive scaffold strength and persistence in the body to enable the optimal remodelling of bone architecture1. As part of the new agreement, genex has been upgraded for the U.S market to include a new closed-mixing system, to shorten preparation time and extend working time.

In addition, it includes a more comprehensive set of delivery options added to allow a surgeon to inject, mold or prepare beads in accordance with their chosen technique.